Selections from Current Literature: Androgenetic Alopecia - The Science Behind a New Oral Treatment
October 1998
in “
Family Practice
”
TLDR New oral treatment, finasteride, effectively and safely treats common hair loss.
This document discusses the need for scientific research and placebo-controlled trials in understanding and treating androgenetic alopecia (AGA), a common form of hair loss. It highlights recent advancements in understanding hair loss and its treatment, including the use of computer imaging and placebo-controlled trials. The article introduces finasteride as a new oral medication for treating AGA and discusses its efficacy and safety. It also explores the psychological impact of male pattern baldness and the need for effective treatments. The article discusses the role of androgens, particularly DHT, in causing hair loss in AGA and the use of 5-alpha-reductase inhibitors as a new oral treatment for the condition.